Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Research Article Volume 7 Issue 2

Comparison Between Magnetic Resonance Spectroscopy and Histopathology in Patients with Meningiomas

Zonaid Kabir1, Momotaj Sohely2, Atikur Rahman3, Sayed Maruf Ur Rahman5, Ferdous Jahan5 and KM Salma6

1Radiologist, National Institute of Kidney Diseases and Urology (NIKDU), Dhaka, Bangladesh
2Lecturer, Department of Community Medicine, Sheikh Hasina Medical College, Tangail, Bangladesh
3Assistant Registrar, Department of Cardiology, National Institute of Cardiovascular Disease and Hospital, Dhaka, Bangladesh
4Medical Officer, Department of Urology, Dhaka Medical College Hospital, Dhaka, Bangladesh
5Resident, Department of Neonatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh
6Radiologist, National Institute of Kidney Diseases and Urology (NIKDU), Dhaka, Bangladesh

*Corresponding Author: Zonaid Kabir, Radiologist, National Institute of Kidney Diseases and Urology (NIKDU), Dhaka, Bangladesh.

Received: November 14, 2023; Published: January 20, 2024

Abstract

Background: Meningiomas are typically benign brain tumors, and their precise characterization is vital for optimal patient management. The comparison between Magnetic Resonance Spectroscopy (MRS) and histopathology in patients with meningioma is a pivotal area of research in the field of neuroimaging and neuropathology.

Aim of the study: The study aimed to compare between magnetic resonance spectroscopy findings and histopathological results in patients with meningioma.

Methods: This was a cross-sectional study conducted at the Department of Radiology & Imaging of Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh during the period from October 2019 to September 2021. A total of 45 suspected cases of meningioma were enrolled in this study as the study subjects purposively. For data collection and analysis, MS Office tools and SPSS Version 23.0 were applied. Results: Magnetic Resonance Spectroscopy (MRS) detected 36 positive cases and 7 negative cases of meningioma. Among the 36 MRS-positive cases, 34 were found to be truly positive upon histopathological examination, indicating a high level of accuracy. However, 2 cases were MRS-positive but turned out to be histopathologically negative, signifying false positives. Additionally, out of the 9 MRS-negative cases, 4 were meningiomas upon histopathological evaluation, which were false negatives, while 5 were genuinely negative.

Conclusion: This analysis suggests that magnetic resonance spectroscopy (MRS) demonstrates a strong ability to correctly identify meningiomas when compared to histopathological diagnosis but has a small rate of both false positives and false negatives.

Keywords: Benign; Histopathology; Magnetic Resonance Spectroscopy; Meningioma; Neuropathology; Tumor

References

  1. Kleihues P and Cavenee WK. “Pathology and genetics of tumors of the nervous system”. IARC (2000).
  2. Toh CH., et al. “Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging”. American Journal of Neuroradiology9 (2000): 1630-1635.
  3. Buetow MP., et al. “Typical, atypical, and misleading features in meningioma”. Radiographics 6 (1991): 1087-1106.
  4. Haaga JR and Boll DT. “CT and MRI of the whole body”. 6th edition, Elsevire (2017): 212-526.
  5. D’Ambrosio AL and Bruce JN. “Treatment of meningioma: an update”. Current Neurology and Neuroscience Reports 3 (2003): 206-214.
  6. Stefanovic J., et al. “Magnetic resonance presentation of intracranial meningiomas”. Global Journal of Medical Research 4 (2011): 33-38.
  7. Majos C., et al. “Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas”. Neuroradiology 3 (2003): 129-136.
  8. Tamrazi B., et al. “Advanced imaging of intracranial meningiomas”. Neurosurgery Clinics of North America 2 (2016): 137-143.
  9. Castillo M and Kwock L. “Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors”. Topics in Magnetic Resonance Imaging2 (1999): 104-113.
  10. Yue Q., et al. “New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma”. European Radiology12 (2008): 2901-2911.
  11. Lin MC., et al. “Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS)”. Plos One11 (2018): e0207612.
  12. Server A., et al. “Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors”. Acta Radiologica3 (2010): 316-325.
  13. Majos C., et al. “Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE”. American Journal of Neuroradiology10 (2004): 1696-1704.
  14. Jaskólski DJ., et al. “Differential diagnosis of intracranial meningiomas based on magnetic resonance spectroscopy”. Neurologia i Neurochirurgia Polska3 (2013): 247-255.
  15. Lin MC., et al. “Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS)”. Plos One11 (2018): e0207612.
  16. Stefanovic J., et al. “Magnetic resonance presentation of intracranial meningiomas”. Global Journal of Medical Research 4 (2011): 33-38.
  17. Gangadhar Kiran., et al. “Imaging Features of Intracranial Meningiomas with Histopathological Correlation: A Relook into Old Disease”. Nepalese Journal of Radiology 10 (2013): 3126.
  18. Demir MK., et al. “Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas”. European Journal of Radiology 1 (2013): 48-55.
  19. Domingo Z., et al. “Role of ischaemia in the genesis of oedema surrounding meningiomas assessed using magnetic resonance imaging and spectroscopy”. British Journal of Neurosurgery5 (1998): 414-418.
  20. Hamsini BC., et al. “Clinical application of MR spectroscopy in identifying biochemical composition of the intracranial pathologies”. GABA and Glutamate-New Developments in Neurotransmission Research (2018).
  21. Matsusue E., et al. “Utility of 3T single-voxel proton MR spectroscopy for differentiating intracranial meningiomas from intracranial enhanced mass lesions”. Acta Radiologica Open4 (2021): 1-10.
  22. Yue Q., et al. “New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma”. European Radiology12 (2008): 2901-2911.
  23. Nakano T., et al. “Meningiomas with brain edema: radiological characteristics on MRI and review of the literature”. Clinical Imaging4 (2002): 243-249.
  24. Paek SH., et al. “Microcystic meningiomas: radiological characteristics of 16 cases”. Acta Neurochirurgica (Wien) 9 (2005): 965-972.

Citation

Citation: Zonaid Kabir., et al. “Comparison Between Magnetic Resonance Spectroscopy and Histopathology in Patients with Meningiomas". Acta Scientific Neurology 7.2 (2024): 29-34.

Copyright

Copyright: © 2024 Zonaid Kabir., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US